Pharma Journalist - Page 770 of 830 -

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO (Sulbactam-Durlobactam)

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Boehringer presents phase III results of adalimumab biosimilar candidate to HUMIRA

Johnson & Johnson Announces Completion of Acquisition of Actelion

Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline

Probiodrug announces encouraging results of the Phase 2a SAPHIR Study

Pfizer Receives Commercialization Rights in Europe for CRESEMBA

Generon announces the initiation of a Phase 1 Clinical Trial for A-337

LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Dermatitis

SGS Expands Extractables and Leachables Testing Capabilities at its Shanghai Facility

JSR Life Sciences agrees to acquire Selexis SA

Axcella Appoints Tony Tramontin as SVP, Chief Scientific Officer